{"symbol":"SYK","fiscalQuarter":"Q2-2026","reportDate":"2026-07-30","reportTime":"AMC","status":"upcoming","company":{"name":"Stryker Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/SYK/earnings/Q2-2026","preBrief":{"companySnapshot":"Stryker Corporation (SYK) is a leading medical technology company that specializes in developing innovative healthcare equipment and devices. With a market cap of $118 billion, Stryker plays a crucial role in the healthcare sector, focusing on improving patient outcomes through advanced surgical and medical solutions.","keyMetrics":[{"name":"Earnings Per Share (EPS)","why":"EPS is a key indicator of the company's profitability and is closely watched by investors.","consensus":"N/A"},{"name":"Revenue Growth","why":"Revenue growth reflects the company's ability to expand its market share and drive sales, which is vital for long-term success.","consensus":"N/A"},{"name":"Surgical Equipment Sales","why":"Sales of surgical equipment are a major revenue driver for Stryker and indicate demand in the healthcare sector.","consensus":"N/A"}],"lastQuarterRecap":{"summary":"In Q1-2026, Stryker reported an EPS of $2.60, which was below analyst expectations of $2.98, resulting in a 12.63% surprise. The stock remained flat the next day, indicating a cautious market reaction.","promises":["Focus on enhancing product innovation and expanding market reach.","Commitment to improving operational efficiencies.","Plans to invest in new technologies to drive future growth."]},"wallStreetExpectations":{"summary":"Overall, expectations for Stryker's upcoming earnings are mixed, with investors looking for signs of recovery after a disappointing Q1. Analysts will be closely monitoring EPS and revenue growth.","bullCase":"If Stryker can exceed EPS expectations and show strong revenue growth, it could signal a rebound in demand for its products, boosting investor confidence.","bearCase":"Conversely, if the company misses on EPS again or shows weak revenue growth, it could raise concerns about its market position and future profitability."},"optionsSignal":{"impliedMove":"1.09%","context":"The options market is pricing in a modest move of 1.09% following the earnings report, suggesting that investors are uncertain about the outcome."},"earningsTrackRecord":[{"quarter":"Q1-2026","epsSurprise":"-12.63%","reaction":"+0.00%"},{"quarter":"Q4-2025","epsSurprise":"+1.71%","reaction":"-0.99%"},{"quarter":"Q3-2025","epsSurprise":"+1.66%","reaction":"-0.17%"},{"quarter":"Q2-2025","epsSurprise":"+2.05%","reaction":"-1.92%"},{"quarter":"Q1-2025","epsSurprise":"+4.18%","reaction":"+0.02%"}],"pivotalQuestions":[{"question":"What will the EPS be for Q2-2026, and how does it compare to previous quarters?","whyItMatters":"The EPS figure will be critical in assessing the company's profitability and could influence investor sentiment significantly."},{"question":"What are the sales figures for surgical equipment this quarter?","whyItMatters":"Sales performance in this key segment will indicate demand trends and the company's competitive position in the healthcare market."}],"thesisBreakLevels":{"bullTrigger":"An EPS of $3.00 or higher would confirm a strong recovery and positive market sentiment.","bearTrigger":"An EPS below $2.50 would raise serious concerns about the company's growth trajectory.","context":"This quarter's performance is pivotal as it follows a disappointing Q1, and investors are looking for signs of improvement."},"scenarioPlaybook":{"beatAndRaise":"If Stryker beats expectations, history suggests the stock could rise by around 0.75% on the day, confirming a positive outlook.","inLineCautious":"If results are in line with expectations, the stock may see muted movement as investors await further clarity in management's commentary.","miss":"If Stryker misses expectations, the average historical reaction suggests a potential decline of around 0.00%, indicating investor disappointment."},"whatTheStreetIsMissing":{"thesis":"The Street may be underestimating Stryker's ability to rebound from the last quarter's miss, especially given its historical track record of beating EPS estimates.","supportingPoints":["Stryker has an 88% EPS beat rate over the last eight quarters, suggesting potential for a positive surprise.","The options market is pricing a smaller move than the historical average, indicating a potential mispricing of volatility."],"riskToConsensus":"If surgical equipment sales show unexpected strength, it could challenge the current bearish sentiment."},"whatToListenFor":["Updates on new product launches and their expected impact on sales.","Any commentary on market demand for surgical equipment.","Insights into cost management strategies and operational efficiencies.","Guidance on future revenue growth and market expansion plans.","Responses to competitive pressures in the healthcare equipment sector."],"metaDescription":"Stryker (SYK) reports Q2 2026 earnings on July 30. Investors are watching for EPS recovery and surgical equipment sales trends."}}